Individual Study / iConquerMS

iConquerMS People-Powered Research Network

iConquerMS People-Powered Research Network

iConquerMS logo
Networks -
Datasets -
Variables -
Start Year
2014
Supplementary Information
https://www.pcori.org/research-results/2015/iconquerms-participant-powered-research-network
Visit iConquerMS

Members

Download
Investigators Contacts
  • Dr. Robert McBurney
    Accelerated Cure Project fo MS
  • Sara Loud
    Accelerated Cure Project for MS

Design

Study design
Registry
Follow Up
Participants were seen at baseline and are followed up every six months.

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
5,500
Number of Participants with Biological Samples
Supplementary Information
The iConquerMS People-Powered Research Network Registry aims to create an active community of 20,000 participants.

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

iConquerMS population

Selection Criteria
Minimum age
21
Newborns
Twins
Countries
  • United States of America
Territory
Massachusetts
Ethnic Origin
Health Status
  • Diagnosed with multiple sclerosis (MS)

Recruitment

Sources of recruitment
  • General population
General Population
  • Volunteer enrolment
Supplementary Information
The Engagement Committee is responsible for the recruitment, engagement, and retention of people affected by Multiple Sclerosis (MS). Recruitment strategy initially relied on the “trusted voice” of leading Multiple Sclerosis (MS) patient bloggers to help promote enrollment in the network. Participants register in the network through its online portal .

Number of Participants

Number of Participants
4,920
Number of Participants with Biological Samples
Data Collection Events
# Name Description Start End
0 iConquerMS - Baseline

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2014-11
1 iConquerMS - Follow-up 1

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2016-08 2017-02
2 iConquerMS - Follow-up 2

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2017-03 2017-06
3 iConquerMS - Follow-up 3

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2017-08 2017-10
4 iConquerMS - Follow-up 4

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2018-03 2018-06
5 iConquerMS - Follow-up 5

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2018-09 2018-12
6 iConquerMS - Follow-up 6

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2019-03 2019-08
7 iConquerMS - Follow-up 7

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2019-09 2019-11
8 iConquerMS - Follow-up 8

Information is collected from participants through surveys which collected information about demographics, Multiple Sclerosis (MS) history, overall health, quality of life, comorbidities, ...

2020-03

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Twin
Marital/partner status
Family and household structure
Education
Residence
Birthplace
Ethnicity, race and religion
Labour force and retirement
Income, possessions, and benefits

Lifestyle and behaviours

Nutrition
Physical activity

Perception of health, quality of life, development and functional limitations

Quality of life
Functional limitations

Diseases

Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the eye and adnexa (H00-H59)
Diseases of the genitourinary system (N00-N99)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
Symptoms and signs involving the digestive system and abdomen (R10-R19)
Symptoms and signs involving the skin and subcutaneous tissue (R20-R23)
Symptoms and signs involving nervous and musculoskeletal systems (R25-R29)
Symptoms and signs involving the urinary system (R30-R39)
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
Symptoms and signs involving speech and voice (R47-R49)
General symptoms and signs (R50-R69)
Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake
Posology and protocol of administration

Non-pharmacological interventions

Radiological interventions
Physical therapy interventions
Cognitive, psychological and sensory interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals

Physical measures and assessments

Physical characteristics
Anthropometry

Administrative information

Date and time-related information
Questionnaire and interview-related information
Other administrative information

Quality of life

Quality of Life in Neurological Disorders
Patient-Reported Outcomes Measurement Information System (Global Health)

Functional limitations

Bladder Control Scale
Bowel Control Scale
Impact of Visual Impairment Scale
Patient-determined Disease Steps
Patient-Reported Outcomes Measurement Information System (Physical function)